BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 12.26 BATS BZX Real-Time Price As of 10:03am ET |  +0.30 / +2.51%Today’s Change | 3.30 Today|||52-Week Range 14.24 | +64.56% Year-to-Date |
Latest BCRX News | Press Releases
| BioCryst Pharmaceuticals Stock Shows Every Sign Of Being Significantly Overvalued May 08 / GuruFocus News - Paid Partner Content | Why BioCryst Pharmaceuticals Stock Is Soaring Today May 06 / MotleyFool.com - Paid Partner Content |
| Strength Seen in BioCryst (BCRX): Can Its 21% Jump Turn into More Strength? May 07 / Zacks.com - Paid Partner Content | BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates May 06 / Zacks.com - Paid Partner Content |
| BioCryst Pharmaceuticals (BCRX) Q1 2021 Earnings Call Transcript May 06 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.96 |
| Today’s open | 11.91 |
| Day’s range | 11.91 - 12.26 |
| Volume | 14,766 |
| Average volume (3 months) | 6,170,544 |
| Market cap | $2.3B |
Data as of 10:03am ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -16.03% |
| Earnings growth (this year) | -2.25% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | -63.53% |
| P/E ratio | NM |
| Price/Sales | 69.96 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXSMAxsome Therapeutics ... | +0.66 | +1.10% |
| ---- | ||
| EDITEditas Medicine Inc | +0.96 | +3.06% |
| NGMNGM Biopharmaceutica... | +0.71 | +2.54% |
Data as of 10:05am ET, 05/14/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $17.8M |
| Annual profit (last year) | -$182.8M |
| Net profit margin | -1,026.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
